[HTML] mdpi.com

[HTML][HTML] Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)

LR Tallini, J Bastida, N Cortes, EH Osorio, C Theoduloz… - Molecules, 2018 - mdpi.com
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …
被引用次数：53 相关文章
[PDF] archive.org

[PDF][PDF] Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)

LR Tallini, J Bastida, N Cortes, EH Osorio… - …, 2018 - scholar.archive.org
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …

Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)

LR Tallini, J Bastida, N Cortes, EH Osorio, C Theoduloz… - Molecules, 2018 - sciprofiles.com
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …

Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae).

LR Tallini, J Bastida, N Cortes, EH Osorio… - …, 2018 - search.ebscohost.com
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …

Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)

LR Tallini, J Bastida, N Cortes, EH Osorio… - …, 2018 - search.proquest.com
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …

Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae).

LR Tallini, J Bastida, N Cortes, EH Osorio… - Molecules (Basel …, 2018 - europepmc.org
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …
[PDF] semanticscholar.org

[PDF][PDF] Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)

LR Tallini, J Bastida, N Cortes, EH Osorio… - …, 2018 - pdfs.semanticscholar.org
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …

Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)

LR Tallini, J Bastida, N Cortes, EH Osorio, C Theoduloz… - agris.fao.org
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer&rsquo: s disease. The chemistry and bioactivity of …

Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean Rhodophiala (Amaryllidaceae)

LR Tallini, J Bastida Armengol, N Cortes… - Molecules, 2018, vol …, 2018 - diposit.ub.edu
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …

Cholinesterase inhibition activity, alkaloid profiling and molecular docking of Chilean Rhodophiala (Amaryllidaceae).

LR Tallini, J Bastida, N Cortes, EH Osorio, C Theoduloz… - 2018 - cabidigitallibrary.org
Amaryllidaceae plants are the commercial source of galanthamine, an alkaloid approved for
the clinical treatment of Alzheimer's disease. The chemistry and bioactivity of Chilean …